HOME >> BIOLOGY >> NEWS
Sea Grant study finds Chinese mitten crabs appear free of human parasite lung flukes

nvasive nuisance species elsewhere. The crabs were first identified in California in 1992, after a shrimp trawler working the South San Francisco Bay hauled up a strange looking crab with fuzzy claws.

However, the crab most likely was introduced to San Francisco South Bay much earlier, in the late 1980s. A hearty and fecund invader, the crab has multiplied to such numbers that it now overruns parts of the bay. In 1998, state workers hauled away about 50 tons worth of mitten crabs that had clogged fish screens at state water pumps near Tracy. Besides clogging fish salvage tanks, mitten crab burrows undermine banks and levees, accelerating erosion and unwanted slumping.

To date, there are no strategies in place for controlling the crab's numbers. Fishers are suggesting that the crab population be culled by opening the mitten crab to commercial fishing, but this is problematic, too.

Dugan said, "The idea is to figure out a way to get rid of the crabs. If you open a fishery, suddenly, they have a value."

Another concern is that parasites could spread like fire in a hayloft through the bay at some later date, because of the sheer number of crabs. Not just people but also raccoons and other animals that feed on mitten crabs could be infected.

Because crayfish are a potential intermediate host for the flukes, the scientists also dissected more than 400 crayfish from the estuary. Like the crabs, all the crayfish appear free of lung flukes.

Despite their findings, the scientists are cautious about concluding that eating the crabs is safe now or in the future.

"Until we finish our survey of the region's snails," Walter said, "we can't assess the risk of future introductions of lung flukes."

The scientists are in the process of analyzing hundreds of freshwater snails from the area to look for evidence of lung flukes. Even if the snails turn up clean, Culver said, there are other major health concerns - such as b
'"/>

Contact: Carrie Culver
c_culver@lifesci.ucsb.edu
805-893-8093
National Sea Grant College Program
14-Nov-2001


Page: 1 2 3

Related biology news :

1. Grant advances biochemical engineering laboratory
2. GlaxoSmithKline Drug Discovery and Development Research Grant Program 2004
3. Grant from GE Foundation to University of Houston to strengthen math, tech pipeline
4. McGill Centre for Intellectual Property Policy receives $3 million SSHRC Grant
5. Grant promotes marine ornamental fish aquaculture
6. Grant of powerful computer to Rutgers-Newark will increase understanding of brain activity
7. Grant renews funding of research toward cloning primates
8. Lipids get the spotlight in new NIGMS Glue Grant
9. Grant funds research to develop tissue-engineered solutions for heart disease
10. Grant strengthens research arm of Penn State Hershey Medical Centers ALS Clinic
11. Sea Grant News & Notes for March 26, 2003

Post Your Comments:
(Date:8/6/2015)... , Aug. 6, 2015 Synaptics Inc. ... human interface solutions, today announced collaboration with Microsoft ... Windows 10. Microsoft leveraged Synaptics, deep expertise in ... system. Through stringent testing, Synaptics, ... certified with Microsoft,s Precision TouchPad (PTP) specification empowering ...
(Date:8/5/2015)... MOUNTAIN VIEW, Calif. , Aug. 5, 2015 /PRNewswire/ ... it exhibits continuous growth in applications, penetration into newer ... year after year. The global biosensors space has seen ... having exited the market so far. (Photo ... from Frost & Sullivan, Analysis of the Global ...
(Date:8/3/2015)... SAN JOSE, Calif. , Aug. 3, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that members ... investment community at the Pacific Crest Global Technology Leadership ... Mountain Time. The conference will be held at the ... The presentation may include forward-looking information. ...
Breaking Biology News(10 mins):Synaptics Chosen for Human Interface Co-Development on Windows 10 2Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4
(Date:8/28/2015)... -- According to a new market research ... Thawing Equipment, Alarms), by Biospecimen (Human Tissue, Stem Cells, ... - Global Forecast to 2020", published by MarketsandMarkets, the ... Million by 2020 from USD 2,150.48 Million in 2015, ... 2020. Browse 74 Tables and 95 ...
(Date:8/28/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: ... focused on the development of autologous cell therapies, ... June 30, 2015, corporate highlights, and near-term milestones.  ... available at www.sedar.com ,  www.edgar.com ... "RepliCel expects to launch its RCS-01 treatment for ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... venture capital funds, investment firms and animal health companies to hear from animal ... $160 million. Several have also received licensing agreements or distribution contracts. This ...
(Date:8/27/2015)... /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC Market: ... Holding Company Limited (Biohaven), announced today that dosing ... BHV-0223, a glutamate modulating agent. Biohaven filed an ... obtained clearance from the U.S. Food and Drug ... holds 54% equity interest in Biohaven, a private ...
Breaking Biology Technology:Biopreservation Market Worth 3,731.03 Million USD by 2020 2Biopreservation Market Worth 3,731.03 Million USD by 2020 3Biopreservation Market Worth 3,731.03 Million USD by 2020 4Biopreservation Market Worth 3,731.03 Million USD by 2020 5RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4
Cached News: